Effects of Trigger Point Dry Needling on Neuromuscular Performance and Pain of Individuals Affected by Patellofemoral Pain: A Randomized Controlled Trial

Figures & data

Table 1 Age, Gender, Height, Weight, and Body Mass Index Between the Two Groups at Baseline

	TrP-DN Group (Mean±SD)	Sham Group (Mean±SD)
Gender (Male/Female)	13/12	10/13
Age (years)	22.48±2.40	25.14±6.02
Height (cm)	170.57±8.13	170.91±9.3
Weight (kg)	66.43±11.72	64.14±12.92
Body Mass Index (kg/m^2)	22.68±2.69	21.84±3.32

Abbreviation: TrP-DN, trigger point dry needling.

Figure 1 The enrollment and outcomes of patients.

Figure 2 The VAS scores in the TrP-DN group and the Sham group.

Notes: *Compared with the same group at pre-treatment p<0.05, ^#Compared with the same group at 3 weeks after treatment p<0.05, ^▲Compared with the control group p<0.05. n=25 in the TrP-DN Group; n=23 in the Sham group. Abbreviations: TrP-DN, trigger point dry needling; Pre, Pre-treatment; 3w, 3 weeks after treatment; 6w, 6 weeks after treatment; 3m, 3 months after treatment.

Figure 3 The Kujala scores in the TrP-DN group and the Sham group.

Notes: *Compared with the same group at pre-treatment p<0.05, ^#Compared with the same group at 3 weeks after treatment p<0.05, ^▲Compared with the control group p<0.05. n=25 in the TrP-DN Group; n=23 in the Sham group.

Abbreviations: TrP-DN, trigger point dry needling; Pre, Pre-treatment; 3w, 3 weeks after treatment; 6w, 6 weeks after treatment; 3m, 3 months after treatment.